David Boutolleau to Compassionate Use Trials
This is a "connection" page, showing publications David Boutolleau has written about Compassionate Use Trials.
Connection Strength
0.041
-
Compassionate Use of Hydroxychloroquine in Clinical Practice for Patients With Mild to Severe COVID-19 in a French University Hospital. Clin Infect Dis. 2021 12 06; 73(11):e4064-e4072.
Score: 0.041